Arterio Bio Co., Ltd., founded in 2012 as a venture from Hokkaido University, specializes in the development and commercialization of functional lactic acid bacteria, particularly Bacillus coagulans lilac-01, used in dietary supplements. The company is known for pioneering the development of lactic acid bacteria extracellular vesicles (EVs) for their health benefits. Arterio Bio's innovative products focus on improving gut health, reducing inflammation, and supporting immune functions.